Search

Your search keyword '"P Ricanek"' showing total 82 results

Search Constraints

Start Over You searched for: Author "P Ricanek" Remove constraint Author: "P Ricanek"
82 results on '"P Ricanek"'

Search Results

1. What is a Goldilocks Face Verification Test Set?

2. Backpropagation-Free 4D Continuous Ant-Based Neural Topology Search

3. Machine Learning and Computer Vision Techniques in Continuous Beehive Monitoring Applications: A survey

4. An Examination of Bias of Facial Analysis based BMI Prediction Models

5. Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)

6. Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

7. Identity Document to Selfie Face Matching Across Adolescence

8. The Future of Smart Health

9. DOP11 A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohorts

11. Phase-based video magnification on a single board computer

12. P487 Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)

13. P353 Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease

14. P240 Low surgery rates first year after diagnosis in Crohn’s disease; results from a large population-based inception cohort - the IBSEN III study

16. Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome.

18. P271 Fecal calprotectin at diagnosis is associated with oral steroid use first year of Inflammatory Bowel Disease

21. Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2.

22. Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland

23. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.

26. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.

27. Health, wealth and longevity: New tools allow science-based financial planning.

28. Su1757 A NOVEL DIAGNOSTIC SERUM PROTEIN SIGNATURE FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE: A DISCOVERY AND VALIDATION STUDY IN TWO INDEPENDENT INCEPTION COHORTS.

29. Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY.

30. Genetic & Evolutionary Biometric Security: Disposable Feature Extractors for Mitigating Biometric Replay Attacks.

31. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease.

32. Systemic Inflammation in Preclinical Ulcerative Colitis.

33. Genetic and evolutionary methods for biometric feature reduction

34. AODTH-008 Proximity extension assay based proteins show immune cell specificity and can diagnose and predict outcomes in inflammatory bowel diseases: ibd character study

35. LESOTHO JOURNEY.

37. OC-047 Epigenetic alterations at diagnosis predict susceptibility, prognosis and treatment escalation in inflammatory bowel disease – ibd character

38. Su1945 - Proximity Extension Assay based Proteins Show Immune Cell Specificity and can Diagnose and Predict Outcomes in Inflammatory Bowel Diseases: IBD Character Study.

39. Su1827 - Epigenetic Alterations at Diagnosis Predict Susceptibility, Prognosis and Treatment Escalation in Inflammatory Bowel Disease and IBD Character.

40. Su1784 PEA Immunoassay Technology Identifies Novel Serum Biomarkers That Can Diagnose and Classify Inflammatory Bowel Diseases: IBD Character Consortium.

41. Epigenetic alterations in inflammatory bowel disease: the complex interplay between genome-wide methylation alterations, germline variation, and gene expression

47. Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study.

48. Fatigue in patients with inflammatory bowel disease in remission one year after diagnosis (the IBSEN III study).

49. Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.

50. Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study.

Catalog

Books, media, physical & digital resources